Table 1.
Baseline Characteristics of Patients with HCC Who Were Cured of BCLC Stage A HCC with Surgical Resection or RFA
| Characteristics | All patients (n=1,491) | Patients treated with resection (n=941) | Patients treated with RFA (n=550) |
p-value |
|---|---|---|---|---|
| Age, yr | 58.6±10.3 | 57.4±9.9 | 60.7±10.6 | <0.001 |
| Male sex | 1,144 (76.7) | 747 (79.4) | 397 (72.2) | 0.001 |
| Etiology | <0.001 | |||
| HBV | 1,152 (77.3) | 779 (82.8) | 373 (67.8) | |
| HCV | 137 (9.2) | 49 (5.2) | 88 (16.0) | |
| Alcohol | 77 (5.2) | 32 (3.4) | 45 (8.2) | |
| NAFLD | 99 (6.6) | 67 (7.1) | 32 (5.8) | |
| Other | 26 (1.7) | 14 (1.5) | 12 (2.2) | |
| Liver cirrhosis | 914 (61.3) | 478 (50.8) | 436 (79.3) | <0.001 |
| MELD score | 7.6±2.2 | 7.0±1.5 | 8.6±2.8 | <0.001 |
| No. of tumors | 1.1±0.4 | 1.1±0.2 | 1.2±0.5 | <0.001 |
| Size of maximal tumor, cm | 2.9±1.8 | 3.4±2.0 | 2.0±0.9 | <0.001 |
| AFP, log10 ng/mL | 1.3±0.9 | 1.4±1.0 | 1.2±0.8 | <0.001 |
| PIVKA-II, log10 mAU/mL | 1.8±0.7 | 1.9±0.7 | 1.7±0.6 | <0.001 |
Data are presented as mean±SD or number (%).
HCC, hepatocellular carcinoma; BCLC, Barcelona Clinic Liver Cancer; RFA, radiofrequency ablation; HBV, hepatitis B virus; HCV, hepatitis C virus; NAFLD, nonalcoholic fatty liver disease; MELD, Model for End-Stage Liver Disease; AFP, alpha-fetoprotein; PIVKA-II, protein induced by vitamin K absence or antagonist II.